Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DFNS vs MRNA✓SelectedUSD · MRNADFNS vs MRNA performance historyLatest closeAs of-11.66%11/18
Stock and ETF performance explorer

DFNS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-97.1%
MRNA return
+293.7%
Excess return
-390.8%
Maximum drawdown
-98.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 6mo.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-11.7%-4.8%-6.8%-11.5%
7D-41.9%-20.9%-21.1%-41.3%
30D-69.7%-13.3%-56.5%-69.6%
3M-94.7%+212.6%-307.3%-94.8%
6M-97.1%+309.0%-406.1%-97.2%
All-97.1%+293.7%-390.8%-97.2%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 6mo: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

6mo analysis · Full analysis span regression · 6 months rolling